| Net Cash Provided by (Used in) Operating Activities |
$214,140 |
USD |
-203% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$150,000 |
USD |
47% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Investing Activities |
$0 |
USD |
|
Q3 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
5,000,000,000 |
shares |
900% |
Q3 2025 |
Q1 2026 |
| Common Stock, Shares, Issued |
2,000,000,000 |
shares |
1143% |
Q3 2025 |
Q1 2026 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$47,257 |
USD |
-13% |
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Valuation Allowance |
$5,241,092 |
USD |
0.66% |
Q2 2025 |
FY 2025 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
|
Q2 2025 |
FY 2025 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
$15,000 |
USD |
|
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$5,249,474 |
USD |
146% |
Q2 2025 |
FY 2025 |
| Additional Paid in Capital |
$809,999 |
USD |
-96% |
Q3 2025 |
Q1 2026 |
| Operating Leases, Future Minimum Payments, Due in Two Years |
$1,500 |
USD |
|
Q3 2025 |
Q1 2026 |
| Depreciation, Depletion and Amortization |
$116,156 |
USD |
-17% |
Q3 2024 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
|
Q2 2025 |
FY 2025 |
| Share-based Payment Arrangement, Expense |
$3,122,808 |
USD |
60% |
Q1 2025 |
Q3 2025 |
| Operating Leases, Future Minimum Payments Due |
$14,207 |
USD |
|
Q3 2025 |
Q1 2026 |
| Interest Expense |
$694,246 |
USD |
2.8% |
Q3 2025 |
Q1 2026 |